Neonatal jaundice, which is caused by high serum levels of unconjugated bilirubin, is usually a temporary condition caused by delayed induction of UGT1A1, the enzyme that conjugates bilirubin for excretion. However, uncontrolled hyperbilirubinemia can cause permanent neurological damage. Here, Muro et al. study the mechanism of bilirubin neurotoxicity in vivo by generating mice that bear a null mutation in the Ugt1 gene. By investigating bilirubin neurotoxicity in two genetic backgrounds, the researchers show that susceptibility to bilirubin damage is strain-specific, thereby underscoring the importance of modifier genes in the modulation of bilirubin toxicity. In addition, by exposing the mice to phototherapy, which converts unconjugated bilirubin to a water-soluble form, at different postnatal times, they identify a window of neuronal susceptibility to bilirubin toxicity. These findings establish Ugt1-null mice as a versatile model in which to study bilirubin neurotoxicity and potential treatments for hyperbilirubinemia. Page 1057
A mouse model for neonatal jaundice
- Split-screen
- Views Icon Views
-
Article Versions Icon
Versions
- Version of Record 01 September 2014
- Share Icon Share
-
Tools Icon
Tools
- Search Site
A mouse model for neonatal jaundice. Dis Model Mech 1 September 2014; 7 (9): e0903. doi:
Download citation file:
Advertisement
Cited by
Call for Papers – Infectious Disease: Evolution, Mechanisms and Global Health
Showcase your latest research on our upcoming Special Issue: Infectious Disease: Evolution, Mechanisms and Global Health. This issue will be coordinated by DMM Editors Sumana Sanyal and David Tobin alongside Guest Editors Judi Allen and Russell Vance. The deadline for submitting articles to this Special Issue has been extended to Monday 24 February 2025.
Biologists @ 100 - join us in Liverpool in March 2025
We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate a DMM programme on antimicrobial resistance on 26 March 2025. Find out more and register to join us in March 2025 in Liverpool, UK. The deadline for abstract submission and early-bird registration is 17 January 2025.
It's about time: the heterochronic background for the 2024 Nobel Prize in Physiology or Medicine
In this Editorial, Bruce Wightman writes about the groundwork laid by investigating the timing of developmental events in nematodes which led to the 2024 Nobel Prize in Physiology or Medicine.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Other journals from
The Company of Biologists